ANOGENITAL DYSPLASIA

This adverse event was reported 150 times

ANOGENITAL DYSPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NELFINAVIR MESYLATE 4 0.0019
1 ETRAVIRINE 7 0.0016
2 RALTEGRAVIR 8 0.0015
3 PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE 1 0.0015
4 MARAVIROC 3 0.0013
5 TESTOSTERONE ENANTHATE 2 0.0012
6 DARUNAVIR 13 0.0009
7 PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION 1 0.0008
8 ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE 3 0.0005
9 IMIQUIMOD 1 0.0004
See all drugs enriched for association with ANOGENITAL DYSPLASIA